Interactive Investor
>>

Syndax Pharmaceuticals Inc (NASDAQ:SNDX) Share Price

SNDX

Syndax Pharmaceuticals Inc

North American company

Right Arrow 1

Healthcare

Right Arrow 2

Biotechnology

 / 

- / -
-
- / -
-
-
-

NAV Price

-

Last Traded

-

Chg

-

-

XNAS

-

Updated: -

Loading...

Times are shown in GMT-5, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.

This stock can be held in:

 / 

- / -
-
- / -
-
-
-

Company Profile

Syndax Pharmaceuticals Inc is a clinical stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.Syndax Pharmaceuticals Inc is a clinical stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications.

NASDAQ:SNDX

US87164F1057

USD

Loading...

Loading Comparison

Latest SNDX News

Currently there are no news & analysis articles for this instrument. Visit our news hub for the latest investment news from ii and Alliance News